SCHEMBL13619927

SCHEMBL13619927

N#Cc1ccc(N(/[N+]([O-])=N/O)C(F)(F)F)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR1H3 Q13133 1/20 0.41
NR1I2 O75469 1/20 0.39
RORA P35398 1/20 0.39
RORC P51449 1/20 0.39
NR1H2 P55055 1/20 0.39
RORB Q92753 1/20 0.39
NR1H4 Q96RI1 1/20 0.39
KIF11 P52732 2/20 0.37
MLYCD O95822 1/20 0.36
CYP19A1 P11511 2/20 0.36
CA2 P00918 3/20 0.35
CA12 O43570 1/20 0.35
CA3 P07451 1/20 0.35
CA6 P23280 1/20 0.35
CA9 Q16790 1/20 0.35
CA14 Q9ULX7 1/20 0.35
CA1 P00915 2/20 0.34
FBP1 P09467 4/20 0.34
PTPN5 P54829 1/20 0.34
NOS3 P29474 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13619938 0.89 NR1H3 (0.39) NR1H3NR1I2RORARORCNR1H2
SCHEMBL13619910 0.85 FBP1 (0.36) NR1H3KIF11CA2CA12CA3
SCHEMBL13619917 0.79 FBP1 (0.38) NR1H3MLYCDCA2CA1FBP1
SCHEMBL16727255 0.76 FBP1 (0.36) NR1H3CA2CA1FBP1MMP3
SCHEMBL13619909 0.76 FBP1 (0.39) NR1H3CA2CA12CA3CA6
SCHEMBL13619931 0.75 ALDH1A1 (0.44) RORCCA2CA9CA1NOS1
SCHEMBL13619928 0.73 TDP1 (0.42) CA2CA12CA3CA6CA9
SCHEMBL13619926 0.73 TSHR (0.42) CA2CA12CA3CA6CA9
SCHEMBL13619912 0.72 FBP1 (0.36) NR1H3CA2CA12CA3CA6
SCHEMBL13619925 0.69 CA1 (0.45) CA2CA1MEN1ALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10273202-B2 Nitroxyl progenitor compounds and methods of use THE JOHNS HOPKINS UNIVERSITY (US) 2019-04-30 US disclosed
US-20090281067-A1 Nitroxyl progenitor compounds and methods of use THE JOHN HOPKINS UNIVERSITY (US) 2009-11-12 US disclosed
US-20090281067-A1 Nitroxyl progenitor compounds and methods of use THE JOHN HOPKINS UNIVERSITY (US) 2009-11-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090281067-A1 Nitroxyl progenitor compounds and methods of use HMOX2, NNMT, HMOX1 NR1H3 213/4885NR1I2 2137/4885RORA 594/4885
US-10273202-B2 Nitroxyl progenitor compounds and methods of use HMOX2, NNMT, HMOX1 NR1H3 213/4885NR1I2 2137/4885RORA 594/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.